Clinical Study to Evaluate the Performance of Perimount Heart Valve in Chinese Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chengwei Zou, M.D
Shandong Provincial Hospital
Principal Investigator - Nan Jiang, M.D
Tianjin Chest Hospital
Principal Investigator - Xufa Chen, M.D
Wuhan Asia Heart Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Wuhan Asia Heart Hospital
Wuhan, Hubei, China
- Shandong Provincial Hospital
Jinan, Shandong, China
- Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Sept 2014
- Primary completion
- 27 Apr 2016
- Completion
- 3 Jun 2020
- Last update posted
- 18 Mar 2022
- Registered enrollment
- 265
- Registry id
- NCT02400489
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.